BRPI1013853A2 - composições tópicas estáveis de derivados de 1,2,4-tiadiazol - Google Patents

composições tópicas estáveis de derivados de 1,2,4-tiadiazol

Info

Publication number: BRPI1013853A2
Authority: BR; Brazil
Prior art keywords: topical compositions; thiadiazole derivatives; stable topical; stable; thiadiazole
Prior art date: 2009-04-24

Application number

BRPI1013853A

Other languages

English (en)

Inventor

Cui Chengji

Zhang Fa

Wong George

Yusuf Mohammed

Mei-King Ng Shirley

Original Assignee

Janssen Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-04-24

Filing date

2010-04-23

Publication date

2019-09-24

2010-04-23 Application filed by Janssen Pharmaceuticals Inc filed Critical Janssen Pharmaceuticals Inc

2019-09-24 Publication of BRPI1013853A2 publication Critical patent/BRPI1013853A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI1013853A 2009-04-24 2010-04-23 composições tópicas estáveis de derivados de 1,2,4-tiadiazol BRPI1013853A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17252609P	2009-04-24	2009-04-24
PCT/US2010/032186 WO2010124175A1 (en)	2009-04-24	2010-04-23	Stable topical compositions for 1,2,4-thiadiazole derivatives

Publications (1)

Publication Number	Publication Date
BRPI1013853A2 true BRPI1013853A2 (pt)	2019-09-24

Family

ID=42237364

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1013853A BRPI1013853A2 (pt)	2009-04-24	2010-04-23	composições tópicas estáveis de derivados de 1,2,4-tiadiazol

Country Status (15)

Country	Link
US (3)	US20100273838A1 (pt)
EP (1)	EP2421521A1 (pt)
JP (1)	JP2012524814A (pt)
KR (1)	KR20120044287A (pt)
CN (1)	CN102458384A (pt)
AU (1)	AU2010238710A1 (pt)
BR (1)	BRPI1013853A2 (pt)
CA (1)	CA2759730A1 (pt)
CL (1)	CL2011002648A1 (pt)
MX (1)	MX2011011206A (pt)
NZ (1)	NZ596138A (pt)
RU (1)	RU2011147592A (pt)
SG (2)	SG175773A1 (pt)
WO (1)	WO2010124175A1 (pt)
ZA (1)	ZA201108618B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7319107B2 (en) *	2001-11-08	2008-01-15	Johnson & Johnson Consumer Companies, Inc.	1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
DK2278962T3 (en)	2008-02-21	2014-03-10	Janssen Pharmaceutica Nv	Methods for the treatment of dermatological disorders
EP2523660A4 (en) *	2010-01-14	2013-07-10	Nuvo Res Inc	FORMATION OF SOLID FORMS OF LOCAL ANESTHESIA FORMULATIONS FOR FIGHTING PAIN
US9132291B2 (en)	2010-10-05	2015-09-15	Dfb Technology, Ltd.	Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
FR2967054B1 (fr) *	2010-11-05	2013-01-25	Lea Lab	Systeme conservateur
US20130045958A1 (en)	2011-05-13	2013-02-21	Trimel Pharmaceuticals Corporation	Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
AR086400A1 (es)	2011-05-13	2013-12-11	Trimel Pharmaceuticals Corp	Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US9757388B2 (en)	2011-05-13	2017-09-12	Acerus Pharmaceuticals Srl	Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20140023979A1 (en) *	2012-07-18	2014-01-23	Maha Mohamed Fouad Mounir	Regeneration of ameloblast cells and dental enamel in vivo
WO2014080283A2 (en) *	2012-11-21	2014-05-30	Trimel Biopharma Srl	Male testosterone titration methods, male intranasal testosterone bio-adhesive gel formulations and use thereof for treating hypogonadism and trt
US11744838B2 (en)	2013-03-15	2023-09-05	Acerus Biopharma Inc.	Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
JP6480847B2 (ja) *	2014-10-15	2019-03-13	第一三共ヘルスケア株式会社	ロキソプロフェン含有外用剤組成物
TW201630606A (zh) *	2015-01-21	2016-09-01	諾華公司	包含局部藥物之蓋崙（ｇａｌｅｎｉｃ）調配物
WO2017103719A1 (en) *	2015-12-15	2017-06-22	Therapeutics Inc.	Halobetasol foam composition and method of use thereof
KR101966673B1 (ko) *	2016-11-21	2019-04-08	에이디인터내셔날㈜	항균탈취 조성물
CN109400724B (zh) *	2018-11-05	2021-04-02	中国科学院烟台海岸带研究所	一种含噻二唑脲类乙酰化淀粉及其制备方法和应用
KR20200053746A (ko) *	2018-11-09	2020-05-19	(주)아모레퍼시픽	졸-겔 조성물
BR112022012974A2 (pt) *	2020-01-08	2022-09-13	Principia Biopharma Inc	Composições farmacêuticas tópicas que compreendem 2-[3-[4-amino-3-(2-fluoro-4-fenóxi-fenil)-1h-pirazolo[3,4-d]pirimidin-1-il]piperidina-1-carbonil]-4,4-dimetilpent-2-eno-nitrila
CN114292689B (zh) *	2021-12-07	2023-03-31	广州崃克保新材料科技有限公司	一种脱模剂组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020103194A1 (en) *	1997-04-30	2002-08-01	Anabella Villalobos	Novel muscarinic receptor agonists
EP0805153B1 (en) *	1996-04-30	2001-11-14	Pfizer Inc.	Novel muscarinic receptor agonists
EP1076648B1 (de) *	1998-04-29	2006-07-12	MERCK PATENT GmbH	Verfahren zur katalytischen herstellung von substituierten bipyridylderivaten
US6294534B1 (en) *	1998-06-11	2001-09-25	Merck & Co., Inc.	Spiropiperidine derivatives as melanocortin receptor agonists
BR0214024A (pt) *	2001-11-08	2004-12-07	Ortho Mcneil Pharm Inc	Derivados de 1,2,4-tiadiazol como moduladores de receptor de melanocortina
US7319107B2 (en) *	2001-11-08	2008-01-15	Johnson & Johnson Consumer Companies, Inc.	1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
US7435429B2 (en) *	2002-02-07	2008-10-14	Trustees Of Columbia University In The City Of New York	Zinc salt compositions for the prevention of dermal and mucosal irritation
DK2278962T3 (en) *	2008-02-21	2014-03-10	Janssen Pharmaceutica Nv	Methods for the treatment of dermatological disorders

2010
- 2010-04-23 CA CA2759730A patent/CA2759730A1/en not_active Abandoned
- 2010-04-23 JP JP2012507412A patent/JP2012524814A/ja active Pending
- 2010-04-23 RU RU2011147592/15A patent/RU2011147592A/ru not_active Application Discontinuation
- 2010-04-23 MX MX2011011206A patent/MX2011011206A/es not_active Application Discontinuation
- 2010-04-23 BR BRPI1013853A patent/BRPI1013853A2/pt not_active IP Right Cessation
- 2010-04-23 EP EP10715466A patent/EP2421521A1/en not_active Withdrawn
- 2010-04-23 CN CN2010800290447A patent/CN102458384A/zh active Pending
- 2010-04-23 SG SG2011077674A patent/SG175773A1/en unknown
- 2010-04-23 WO PCT/US2010/032186 patent/WO2010124175A1/en not_active Ceased
- 2010-04-23 AU AU2010238710A patent/AU2010238710A1/en not_active Abandoned
- 2010-04-23 KR KR1020117027782A patent/KR20120044287A/ko not_active Withdrawn
- 2010-04-23 SG SG10201401006QA patent/SG10201401006QA/en unknown
- 2010-04-23 US US12/765,981 patent/US20100273838A1/en not_active Abandoned
- 2010-04-23 NZ NZ596138A patent/NZ596138A/xx not_active IP Right Cessation
2011
- 2011-10-24 CL CL2011002648A patent/CL2011002648A1/es unknown
- 2011-11-23 ZA ZA2011/08618A patent/ZA201108618B/en unknown
2013
- 2013-03-15 US US13/836,370 patent/US20130203823A1/en not_active Abandoned
- 2013-03-15 US US13/835,418 patent/US20130210868A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2012524814A (ja)	2012-10-18
ZA201108618B (en)	2013-05-29
NZ596138A (en)	2013-11-29
US20130210868A1 (en)	2013-08-15
AU2010238710A1 (en)	2011-11-17
EP2421521A1 (en)	2012-02-29
CL2011002648A1 (es)	2012-07-20
SG10201401006QA (en)	2014-10-30
US20100273838A1 (en)	2010-10-28
KR20120044287A (ko)	2012-05-07
WO2010124175A1 (en)	2010-10-28
MX2011011206A (es)	2012-02-28
RU2011147592A (ru)	2013-05-27
US20130203823A1 (en)	2013-08-08
CN102458384A (zh)	2012-05-16
CA2759730A1 (en)	2010-10-28
SG175773A1 (en)	2011-12-29

Publication	Publication Date	Title
BRPI1013853A2 (pt)	2019-09-24	composições tópicas estáveis de derivados de 1,2,4-tiadiazol
BRPI1011952A2 (pt)	2016-04-26	"composições de combustível compreendendo derivados de isopreno"
SMT201600198B (it)	2016-08-31	Derivati di 1,2,4-triazina-4-ammina
BRPI1009982A2 (pt)	2017-06-27	composição antimicrobiana hidratante
BRPI1009281A2 (pt)	2016-03-08	composição oftálmica tópica
BR112012015868A2 (pt)	2017-06-20	derivados de imidazolidinadiona
LT3061445T (lt)	2023-09-25	Labai koncentruotos farmacinės kompozicijos
DK3078664T3 (da)	2019-05-13	Antiparasitiske dihydroazol-sammensætninger
ES2628203T8 (es)	2021-08-23	Composiciones antitranspirantes
EP2488022A4 (en)	2014-02-19	Compositions
BR112012005237A2 (pt)	2016-03-15	utilização de composições ternárias
ECSP12011999A (es)	2012-07-31	Derivados benzamida sustituidos
UY33161A (es)	2011-07-29	Composiciones plaguicidas
DOP2011000396A (es)	2012-02-15	Composiciones novedosas
DK2391349T3 (da)	2014-11-03	Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
FR2933868B1 (fr)	2012-08-17	Compositions cosmetiques
EP2445345A4 (en)	2013-04-24	benzamide derivatives
LT2966175T (lt)	2019-08-26	Farmacinės kompozicijos turinčios korteksolono-17-alfa-propionato
BRPI1010690A2 (pt)	2016-03-15	composições
BRPI1008215A2 (pt)	2016-03-01	"composição azeotrópica"
BR112012005680A2 (pt)	2016-02-23	composição de higiene pessoal
CR10879A (es)	2009-08-05	Cyclized derivatives as eg-5 inhibitors
BRPI1007452A2 (pt)	2016-02-16	formulações galênicas de compostos orgânicos
EP3348251C0 (en)	2024-01-17	SUN PROTECTION COMPOSITIONS
DK2170292T3 (da)	2014-04-07	Atazanavirholdige sammensætninger i tabletform

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2020-01-21	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.